Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person High expression of the membrane protein CD163 in macrophages...

Class:IdSummation:9662865
_displayNameHigh expression of the membrane protein CD163 in macrophages...
_timestamp2019-12-11 13:58:52
created[InstanceEdit:9662752] Murillo, Julieth, 2019-09-24
literatureReference[LiteratureReference:9662853] CD163 and inflammation: biological, diagnostic, and therapeutic aspects
[LiteratureReference:9662841] sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
[LiteratureReference:9662798] The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression
modified[InstanceEdit:9662900] Murillo, Julieth, 2019-09-24
[InstanceEdit:9665516] Murillo, Julieth, 2019-10-31
[InstanceEdit:9670580] Murillo, Julieth, 2019-12-11
textHigh expression of the membrane protein CD163 in macrophages is a characteristic of tissues responding to inflammation elicited either by an intracellular pathogen infection (such as Mycobacterium leprae or Leishmania spp.) or due to an acute or chronic inflammatory disorder. The soluble form of this molecule, sCD163, is considered to be a potential inflammation biomarker and a therapeutic target; sCD163 is formed from the increased shedding of CD163 mediated by the tumor necrosis factor-α (TNF-α) cleaving enzyme, ADAM17 (Etzerodt & Moestrup 2013, Silva et al. 2017). The biological function of sCD163 is not yet clear, although several possible functions have been proposed: opsonization of Staphylococcus aureus, inhibition of T-cell proliferation and inhibition of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) (Tran et al. 2005).
(summation)[Pathway:9662834] CD163 mediating an anti-inflammatory response [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by High expression of the membrane protein CD163 in macrophages... (9662865)